TTR (1 companies · 4 programs)

Intellia Therapeutics, Inc. NTLA

• nexiguran ziclumeran — Transthyretin Amyloidosis with Cardiomyopathy Phase 3
• nexiguran ziclumeran — Hereditary Transthyretin Amyloidosis with Polyneuropathy Phase 3
• nexiguran ziclumeran — ATTR Amyloidosis with Cardiomyopathy Phase 3
• nexiguran ziclumeran — Hereditary ATTR Amyloidosis with Polyneuropathy Phase 3